Categories: News

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2023 on Thursday, November 9, 2023

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MARLBOROUGH, Mass.–(BUSINESS WIRE)–$HOLX #earnings–Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2023 on Thursday, November 9, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.


Interested participants may listen to the call by dialing (866) 400-0049 (in the United States and Canada) or +1 (773) 305-6867 (for international callers) and referencing access code 1937661. Participants may also click here to join. Participants should dial in 5-10 minutes before the call begins. A webcast replay will be available approximately two hours after the call ends.

Hologic will provide a live and webcast replay of the call on the Company’s website at investors.hologic.com. The call will be available there for 30 days.

About Hologic

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

SOURCE: Hologic, Inc.

Contacts

Paula Izidoro

Manager, Investor Relations and Social Media

858-410-8904

paula.izidoro@hologic.com

Staff

Recent Posts

The Love for Liam Foundation to Host the Fourth Annual Liam Johnson Memorial Golf Outing & Benefit Dinner on May 2, 2025

PHILADELPHIA, April 24, 2025 (GLOBE NEWSWIRE) -- The Love for Liam Foundation, a 501(c)(3) nonprofit…

2 seconds ago

Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

HOUSTON, TX, April 24, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the…

6 seconds ago

Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference

– Data to be presented supports development of rademikibart for patients with moderate-to-severe asthma or…

16 seconds ago

INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”

SARASOTA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: NAYA), formerly known…

20 seconds ago

AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025

VALENCIA, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH),…

33 seconds ago